Biomolecular insights into protein-insolubility-related disease miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Researchers at Kanazawa University elucidate in Frontiers in Molecular Biosciences how small biocontainers enclosed by membranes are involved.
Alzheimer's disease (AD) involves the deposition of a protein called amyloid β protein (Aβ) in the brain. This protein can build up in both the functional tissues, or "parenchyma", of the brain, and in the blood vessels.
As the global population ages, the rate of dementia is increasing worldwide. Given that early detection is critical for treatment, effective ways to screen for dementia are a high research priority.
Researchers from Kanazawa University developed a new test for dementia and mild cognitive impairment. The computerized assessment battery for cognition (C-ABC) was able to accurately discriminate mild cognitive impairment from normal cognition, and also distinguish dementia from mild cognitive impairment and normal cognition, and took only 5 minutes to complete. This test could increase the early detection of dementia, thus improving treatment options and outcomes for this patient group.